Exploratory Study of ADR-002K for Heart Failure Patients with Ischemic Heart Disease who Undergo Coronary Artery Bypass Surgery
Not yet recruiting
- Conditions
- Heart Failure Patients with Ischemic Heart Disease who Undergo Coronary Artery Bypass Surgery
- Registration Number
- jRCT2053250022
- Lead Sponsor
- ROHTO Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- Patients who are clinically diagnosed heart failure with ischemic heart disease and receive CABG
- Patients with a left ventricular ejection fraction of 40% or less before CABG
- Others
Exclusion Criteria
- Patients who have a combination of cardiovascular disease such as severe organic valvular disease
- Patients whose participation in a clinical trial is considered inappropriate at the discretion of the investigator or co-investigator
- Others
Study & Design
- Study Type
- Interventional
- Study Design
- parallel assignment
- Primary Outcome Measures
Name Time Method - Heart Failure Event
- Secondary Outcome Measures
Name Time Method